Navigation Links
SWOG cancer trials network awarded over $120 million in NCI grants
Date:4/9/2010

ANN ARBOR, Mich. Noting that the organization's research "has touched the lives of virtually every adult cancer patient in this nation," the National Cancer Institute (NCI) has renewed the Southwest Oncology Group's operating grants for six years, with a total funding package over that period expected to exceed $120 million.

The award was announced at a Friday press briefing by Group Executive Officer Anne F. Schott, M.D., and Michigan Congressman John Dingell.

The Southwest Oncology Group (SWOG) is a clinical research cooperative group that designs and conducts large-scale trials of new cancer treatments and prevention regimens. The Group is headquartered at the University of Michigan, but its network of almost 5,000 affiliated researchers and more than 500 institutions, including 19 of the NCI-designated cancer centers, extends across the U.S. and into several other countries.

"We're proud to be first among the ten NCI cooperative groups to embrace and to be funded for comparative effectiveness research as part of our mission," says SWOG Group Chair Laurence H. Baker, D.O., referring to recent Group initiatives to develop more formal methods of identifying which studies will have the greatest clinical benefit. Baker is professor of internal medicine and pharmacology at the University of Michigan Medical School.

The principal grant, more than $63 million, will be administered by the University of Michigan Medical School and is the largest single research award ever to that school. Most of the remainder of the NCI package will be distributed directly to the Group's member institutions.

The NCI committee that reviewed the grant application praised the Group's "outstanding record of productivity," citing the more than 300 peer-reviewed publications that document SWOG trial results during the previous five-year grant cycle.

The grant package supports the Group's Ann Arbor headquarters, its operations off
'/>"/>

Contact: Frank DeSanto
fdesanto@umich.edu
734-998-0114
University of Michigan Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Hepatitis C Tied to Higher Kidney Cancer Risk
2. Research Reveals Cancer Drug Effectiveness Substantially Advanced
3. Progress Made Against Tough-to-Treat Biliary Tract Cancers
4. "An Evening of Hope” - The Official Pre-Event for This Year's American Cancer Society Starry Night Gala
5. Researchers discover new approach for identifying smokers at highest risk for developing lung cancer
6. Urine test for kidney cancer a step closer to development
7. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
8. Simple Test May Spot Early Lung Cancer
9. New agent chokes off energy supply, kills cancer cells
10. Cancer Drug Safe for Late-Stage Pelvic Disease
11. New study implicates health care utilization, over biology, in colorectal cancer disparities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... Uniondale, NY and Greenwich, CT (PRWEB) , ... ... ... Therapy (“Professional”), a Great Point Partners I, L.P. (“GPP”) portfolio company has acquired ... and Connecticut — incorporating it into its portfolio of state-of-the-art clinics. , “Our ...
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder ... foundation, making hers the very first small business donation to kick off the campaign ... over thirty years. Her legacy includes a complete line of raw, organic hair care ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Times magazine. What are the STASH awards? The Significant Technological Achievements in ... the cannabis-cultivation community as well as tried-and-true products that have stood the test ...
(Date:7/31/2015)... ... ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened a ... July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and Latin ... Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department of ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only Thermage ... also the first provider of Exilis non-surgical fat reduction in New York. Due ... attracted a large International clientele. Many patients travel to New York to get ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:March4thforWellBeing Foundation Kickoff 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4
... the price we pay for a natural defence mechanism. The ... and cancer in later life. Says a research published in ... of the bacteria, known as propionibacteria (P. acnes), may help ... effective at tackling subsequent infections. It appears that P. acnes ...
... behind some early miscarriages, preliminary research suggests. The hormone, ... mother and the embryo soon after it implants itself ... left vulnerable to attack from the mother's immune system.// ... Fas ligand (FasL) that keeps maternal immune system cells ...
... 21, is a chromosomal disorder occurring in roughly one in ... mental retardation and a range of physical deformities, including a ... less in early pregnancy. Detecting Down syndrome early in pregnancy ... face. // ,British scientists say failure to detect ...
... later a fertilised egg implants in a woman's uterus, the ... has found.The report in the latest New England Journal of ... - the true start of pregnancy - influences its success ... lining of the womb anywhere from six to 12 days ...
... unique protein that only occurs in sperm could be the ... protein, named CatSper, is an ion channel protein that controls ... in enabling sperm to swim, so a drug designed to ... ,The discovery is reported in this week's Nature by Dr ...
... while trying to have a baby risk having to ... Institute of Health Sciences at Oxford University compared the ... and never-smokers. Their findings show that on average women ... almost two months longer to conceive than non-smokers. // ...
Cached Medicine News:
(Date:7/31/2015)... N.J. and SAN DIEGO ... that its parent company Eisai Co., Ltd. (Headquarters: ... Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Dr. Helen Torley , "NASDAQ: HALO") have signed ... (brand name: Halaven ® , "eribulin") in combination with ...
(Date:7/31/2015)... July 31, 2015 According to ... by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), ... - Global Analysis & Forecast to 2019", published by ... at $911.1 Million 2014 and is estimated to grow ... of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation ... of heart valves and hemodynamic monitoring, today announced that ... of Directors. "Bob is an ardent champion for ... true privilege to have him on Edwards, board as we ... , Edwards, chairman and CEO.  "Bob has provided a valuable ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... YORK, Feb. 6, 2012 Reportlinker.com announces ... available in its catalogue: , ... Antivirals) http://www.reportlinker.com/p0769020/World-Market-for-Anti-Infectives-Antifungals-Antibacterials-and-Antivirals- ... Information report – The World Market ...
... Conn., Feb. 3, 2012 Boehringer Ingelheim presented ... Aggrenox® (aspirin/extended-release dipyridamole), an antiplatelet medication, is not ... pump inhibitor (PPI), frequently used to treat several ... International Stroke Conference (ISC) in New Orleans. ...
Cached Medicine Technology:World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 2World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 3World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 4World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 5World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 6World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 7World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 8World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 9Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI 2Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: